CD274 and renal cell carcinoma: More recently, two studies found that CD274 (or PD-L1) gene amplifications are present in S RCC tumors and suggested that this genomic alteration may be underlying the increased PD-L1 tumor expression in these tumors and hypothesized that this genomic amplification may be underlying the immune responsiveness of S RCC tumors6,17.